CULLEN TANIGUCHI to Proto-Oncogene Proteins p21(ras)
This is a "connection" page, showing publications CULLEN TANIGUCHI has written about Proto-Oncogene Proteins p21(ras).
Connection Strength
0.196
-
Selective EGLN Inhibition Enables Ablative Radiotherapy and Improves Survival in Unresectable Pancreatic Cancer. Cancer Res. 2019 05 01; 79(9):2327-2338.
Score: 0.100
-
Circulating Nucleic Acids Are Associated With Outcomes of Patients With Pancreatic Cancer. Gastroenterology. 2019 01; 156(1):108-118.e4.
Score: 0.096